Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease

Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease

Background: The safety of bevacizumab in combination with chemotherapy in patients with inflammatory bowel disease (IBD) and digestive and nondigestive cancers is poorly documented. Methods: We retrospectively evaluated patient records of all adult cancer patients with IBD at our institution from Ap...

Full description

Bibliographic Details
Main Authors: Ruth Gabriela Herrera-Gómez, Miruna Grecea, Claire Gallois, Valérie Boige, Patricia Pautier, Barbara Pistilli, David Planchard, David Malka, Michel Ducreux, Olivier Mir
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
inflammatory bowel disease
ulcerative colitis
Crohn’s disease
bevacizumab
chemotherapy
cancer
Online Access:https://www.mdpi.com/2072-6694/14/12/2914

Internet

https://www.mdpi.com/2072-6694/14/12/2914

Similar Items